United States · FDA National Drug Code directory

Budesonide Inhalation Suspension

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 69097-319_29644146-4bcf-49d0-80b3-e31f4b3a6f54
Product NDC: 69097-319
Form: INHALANT
Composition / generic term: Budesonide
Labeler: Cipla USA Inc.
Marketing category: ANDA
Marketing start / end (source format): 20171116
Source listing expiry: 20271231

Source-listed ingredients

BUDESONIDE — .5 mg/2mL

These values do not establish equivalence or a dose recommendation.

Packages

30 POUCH in 1 CARTON (69097-319-53) / 1 AMPULE in 1 POUCH (69097-319-32) / 2 mL in 1 AMPULE · 69097-319-53
6 POUCH in 1 CARTON (69097-319-87) / 5 AMPULE in 1 POUCH (69097-319-86) / 2 mL in 1 AMPULE · 69097-319-87

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →